In a new study published today in JCI Insight, researchers from Cedars-Sinai Medical Center have demonstrated that thinning of the retina – the light-sensitive tissue in the back of the eye – may serve as an early indicator of Alzheimer's disease up to seven years before cognitive symptoms manifest.
This groundbreaking research builds on existing evidence linking neurodegenerative processes in the brain to observable changes in ocular anatomy. Using advanced optical coherence tomography (OCT) scans on 70 participants with confirmed Alzheimer's diagnoses and 70 cognitively healthy controls, scientists found consistent patterns of retinal layer thinning in disease-associated regions among those who later developed dementia.
The study's lead author, Dr. Maya Koronyo-Hamaoui, noted that the findings could revolutionize early intervention strategies: "The ability to detect Alzheimer's pathology through a simple, non-invasive eye exam represents a paradigm shift in our approach to this devastating disease. Current diagnostic methods require expensive brain imaging or lumbar punctures, which are impractical for widespread screening."
Researchers emphasized the correlation between specific retinal layers affected and the accumulation of amyloid-beta plaques – hallmark pathological features of Alzheimer's. The technology's potential for integration into routine medical check-ups could enable population-level monitoring and facilitate enrollment in preventive clinical trials at earlier stages.
While further validation with larger, diverse cohorts is needed, this research marks significant progress toward affordable, accessible Alzheimer's diagnostics. The team is now exploring machine learning applications to enhance OCT scan analysis and improve predictive accuracy across different demographic groups.
【全文结束】
